http://rdf.ncbi.nlm.nih.gov/pubchem/reference/27010840

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Validation Study
endingPage 705
issn 1875-8908
1387-2877
issueIdentifier 2
pageRange 691-705
publicationName Journal of Alzheimer's disease : JAD
startingPage 691
bibliographicCitation Klafki HW, Hafermann H, Bauer C, Haussmann U, Kraus I, Schuchhardt J, Muck S, Scherbaum N, Wiltfang J. Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort. J Alzheimers Dis. 2016 Sep 06;54(2):691–705. doi: 10.3233/jad-160398. PMID: 27567847.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5af6cb9efb1ad7a59f965dafce81c7f8
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-1062-4453
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_65bc1df44b64d9df87d03bf8017160c7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7454b7b71f933faf011b6003b98f550c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1492-5330
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e8610e381be1ea316c9c49e8669a686a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c4d27ff04276d955c950e047079d124a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c1d56d63fc2fcfb809173eb360d86601
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ad5baf237ec9d9194ad849b9cf116af5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aa9523b4b5483e25eeac5a3247b52558
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0ad43e4d6e774764f663695794e5ea0c
date 2016-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/27567847
https://doi.org/10.3233/jad-160398
isPartOf https://portal.issn.org/resource/ISSN/1387-2877
https://portal.issn.org/resource/ISSN/1875-8908
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
title Validation of a Commercial Chemiluminescence Immunoassay for the Simultaneous Measurement of Three Different Amyloid-β Peptides in Human Cerebrospinal Fluid and Application to a Clinical Cohort
discusses http://id.nlm.nih.gov/mesh/M0023752
http://id.nlm.nih.gov/mesh/M0210619
http://id.nlm.nih.gov/mesh/M0016224
http://id.nlm.nih.gov/mesh/M0024786
http://id.nlm.nih.gov/mesh/M0202730
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D000544Q000134
http://id.nlm.nih.gov/mesh/D010446Q000134
http://id.nlm.nih.gov/mesh/D016229Q000134
http://id.nlm.nih.gov/mesh/D049449
hasSubjectTerm http://id.nlm.nih.gov/mesh/D015415Q000134
http://id.nlm.nih.gov/mesh/D004797Q000592
http://id.nlm.nih.gov/mesh/D000544Q000175
http://id.nlm.nih.gov/mesh/D008875
http://id.nlm.nih.gov/mesh/D005260
http://id.nlm.nih.gov/mesh/D008297
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D000369
http://id.nlm.nih.gov/mesh/D015331
http://id.nlm.nih.gov/mesh/D000368

Total number of triples: 49.